2 Stocks to Buy Now Before Earnings for Big Growth Upside

 | Jun 21, 2021 07:12AM ET

Second quarter earnings season unofficially kicks off in mid-July with the big banks such as JPMorgan FDX , and other giants due out this week.

Stocks climbed to start the week of June 21, with the S&P 500 up 1.4% and the Nasdaq 0.80% higher on the day. The Dow also surged 1.8% Monday to bounce back from its worst week since the end of October. Wall Street sold stocks last week after the Fed signaled that they expect to lift interest rates sooner than previously anticipated.

Monday’s comeback came a week after investors pushed the tech-heavy Nasdaq to fresh records for the first time since late April. The benchmark index also hit new highs last week and investors might continue to push stocks higher.

The Fed has signaled it likely won’t raise rates until 2023 and even when they do rates will remain historically low, forcing Wall Street to keep chasing returns in equities. Plus, the continually improving earnings picture, coupled with the grand U.S. economic reopening might keep the bullish sentiment alive much longer, despite legitimate overheating and inflation fears (also read: Making Sense of Q2 Earnings Season Expectations ).

With this in mind, let’s dive into two companies that are set to report their earnings results this week to see if either stock is worth buying…

Darden Restaurants (NYSE:DRI) DRI

Darden is a dine-in restaurant chain standout, with brands from Olive Garden and LongHorn Steakhouse to Yard House and The Capital Grille. The company’s portfolio includes over 1,800 restaurants and it continues to expand. The sit-down dining powerhouse was hit far worse than the likes of Chipotle CMG and other eateries more custom to take-out, with DRI’s revenue down big over the last four quarters.

Luckily, Darden’s outlook calls for a return to growth and its positive guidance helped DRI climb to new highs after its Q3 release in late March. And the U.S. economic reopening is set to help the Olive Garden owner rebound in a big way as people clamor to return to their pre-pandemic lives. Darden’s consensus earnings outlook has soared since its last report, including some strong positive revisions leading up to its Q4 FY21 release on Thursday, June 24.

Zacks estimates call for Darden to swing from an adjusted loss of -$1.24 all the way to +$1.80 per share, while its Q4 revenue is projected to skyrocket 72%. DRI’s FY21 sales are still expected to dip 9%, even though its adjusted earnings are expected to jump 30%. But Wall Street is looking ahead to better days.

DRI’s FY22 revenue is projected to soar 30% to reach $9.23 billion. This would mark by far its largest growth as a public firm—went public in the mid-1990s—and see it climb above its pre-pandemic levels of $8.5 billion. This top-line expansion is projected to boost its adjusted FY22 EPS by 75%.

Get The News You Want
Read market moving news with a personalized feed of stocks you care about.
Get The App